Universe Pharmaceuticals INC
- Last sale
- Nov 12, 2026 · -2.80%
- Market cap
- —
- no share count on file
- Filings
- 119
FY 2025−22.4% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+13.9% FY25 yoy
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-09-30 | $17,858,732,000 | reported | |
| FY 2024 | 2024-09-30 | $23,024,458,000 revised | reported | |
| FY 2023 | 2023-09-30 | $32,308,735,000 revised | reported | |
| FY 2022 | 2022-09-30 | $40,143,151 | reported | |
| FY 2021 | 2021-09-30 | $47,982,031 | reported | |
| FY 2020 | 2020-09-30 | $30,703,960 | reported | |
| FY 2019 | 2019-09-30 | $33,229,316 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2019 | $16.01M | — | $16.01M | — | — | — | 122.0% |
Segments
Products
LineFY2025ShareChange
Revenue from sales of self-manufactured TCMD products$13.26B74%−5.5%
Revenue from sales of third-party products$4.60B26%−48.9%
Total$17.86B
Pharmaceutical preparations
Universe Pharmaceuticals INC is the 9th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BMYBristol Myers Squibb Co$48.2B0.2%14.6%$127.4BABTAbbott Laboratories$44.3B5.7%14.7%$185.8B
UPCUniverse Pharmaceuticals INC (this company)$17.9B22.4%20.6%—
TEVATeva Pharmaceutical Industries Ltd$17.3B4.3%8.2%$50.9BREGNRegeneron Pharmaceuticals, Inc.$14.3B1.0%31.4%$96.0BVTRSViatris Inc$14.3B3.0%24.6%$23.7BVRTXVertex Pharmaceuticals Inc$12.0B8.9%32.9%$137.6BBHCBausch Health Companies Inc.$10.3B6.7%1.5%$3.1BZTSZoetis Inc.$9.5B2.3%28.2%$33.7BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Universe Pharmaceuticals INC · CIK 1809616 · Engraved from SEC EDGAR